sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 326-350 out of 1337.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>

Public Release: 7-Nov-2016
Lancet
Funding a set of essential medicines for low- and middle-income countries
As the world moves toward universal health coverage, the question arises: how can governments ensure equitable access to essential medicines in low- and middle-income countries? A section of The Lancet Commission on Essential Medicines Policies report co-written by Corrina Moucheraud, assistant professor of health policy and management at the UCLA Fielding School of Public Health, provides the first comprehensive model estimating the cost to provide essential medicines for all people in these countries.

Contact: Enrique Rivero
erivero@mednet.ucla.edu
310-267-7120
University of California - Los Angeles Health Sciences

Public Release: 7-Nov-2016
UNC scientists named to European Union-funded global Zika research consortium
Two researchers at the UNC School of Medicine have been named to a global consortium for Zika research and vaccine development. Aravinda de Silva, PhD, professor of microbiology and immunology, and Stefan Metz, PhD, a post-doc in de Silva's lab, make up one of only two US teams to be named to the European Union-funded worldwide initiative. Sponsored by the European Union's Horizon 2020 Programme, the consortium is investing $49 million in Zika research across the globe.

Contact: Caroline Curran
caroline.curran@unchealth.unc.edu
984-974-1146
University of North Carolina Health Care

Public Release: 7-Nov-2016
Nature
Early study finds antibody that 'neutralizes' Zika virus
Researchers studied Zika survivors and made human monoclonal antibodies from their B cells that kill the virus. In mouse models of infection including pregnant mice, some of the antibodies protect against infection and disease including the fetuses.
National Institutes of Health

Contact: Craig Boerner
craig.boerner@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 7-Nov-2016
Nature
Antibody protects against fetal disease in mouse model of Zika infection
Administering a human antibody that neutralizes Zika virus to pregnant mice before or after Zika virus infection reduced levels of the virus in placental and fetal tissues and decreased fetal disease, new findings show. The work may aid development of vaccines and therapies for Zika virus infection, which can cause severe birth defects when it occurs during pregnancy.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Hillary Hoffman
hillary.hoffman@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 7-Nov-2016
Proceedings of the National Academy of Sciences
Mosquito-borne illness spreads in and around homes, disproportionately hits women
Outbreaks of the mosquito-borne disease chikungunya appear to be driven by infections centered in and around the home, with women significantly more likely to become ill, suggests new research from the Johns Hopkins Bloomberg School of Public Health, the Institut Pasteur in Paris and the International Centre for Diarrhoeal Disease Research, Bangladesh.
US Centers for Disease Control and Prevention, NIH/National Institute of Allergy and Infectious Diseases

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 4-Nov-2016
An integrated approach to HIV prevention
The Medical University of South Carolina has received a $3.1 million grant from the National Institutes of Health to study an integrated approach of screening and treatment for HIV, diabetes, and hypertension in Tanzania. In an earlier small study, this approach resulted in a 97 percent increase in HIV testing over twelve months. This new trial is a collaborative effort between MUSC, Clemson University, and Muhimbili University of Health and Allied Sciences in Tanzania.
National Institutes of Health

Contact: Heather Woolwine
woolwinh@musc.edu
843-792-7669
Medical University of South Carolina

Public Release: 3-Nov-2016
The Open Dentistry Journal
Dental occlusion and ophthalmology: A literature review
Dental Occlusion and Ophthalmology: A Literature Review is a summary of many years of research and dental clinic of Orofacial Pain Department directed by Professor Monaco of University of L'Aquila on a complex subject: connections between temporomandibular joints and vision. The authors' primary goal is to give clinical advice starting from the study of anatomical and functional connections between dental occlusion and vision.

Contact: Faizan ul Haq
faizan@benthamscience.org
Bentham Science Publishers

Public Release: 3-Nov-2016
Lancet Infectious Diseases
Two genetic markers that predict malaria treatment failure found
A malaria treatment that combines fast-acting dihydroartemisinin with long-lasting piperaquine is quickly losing power in Cambodia due to the rapid spread of drug-resistant parasites. The presence of piperaquine-resistant malaria parasites in several Cambodian provinces was confirmed earlier this year. Now, by comparing the complete genomes of 297 parasites isolated from Cambodian malaria patients to a reference malaria parasite genome, researchers identified two genetic markers that are strongly associated with the parasites' ability to resist piperaquine.
NIH/National Institute of Allergy and Infectious Diseases

Contact: NIAID Office of Communications
niaidnews@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 3-Nov-2016
IDRI receives $15 million commitment from Eli Lilly for TB drug discovery
IDRI's drug discovery efforts continue to grow with a recently awarded $7.5 million in additional funding, plus an additional $7.5 million of in-kind services, for a total commitment of $15 million over the next five years from Eli Lilly and Company.
Eli Lilly and Company

Contact: Lee Schoentrup
lee.schoentrup@idri.org
425-354-8132
Infectious Disease Research Institute

Public Release: 3-Nov-2016
Cell
New TSRI study suggests Ebola can adapt to better target human cells
A new study co-led by scientists at The Scripps Research Institute (TSRI) suggests that Ebola virus gained a genetic mutation during the 2013-16 epidemic that appears to have helped it better target human cells.
National Institutes of Health, NIH/National Institute National Institute on Drug Abuse, NIH/National Institute of Allergy and Infectious Diseases, NIH/National Human Genome Research Institute, NIH/National Center for Advancing Translational Sciences

Contact: Madeline McCurry-Schmidt
madms@scripps.edu
858-784-9254
Scripps Research Institute

Public Release: 3-Nov-2016
Lancet Infectious Diseases
Genetic marker found for resistance to malaria treatment in Cambodia
Scientists at the Wellcome Trust Sanger Institute and their collaborators have discovered genetic markers in malaria parasites linked with resistance to the anti-malarial drug piperaquine. Reported in Lancet Infectious Diseases, this research will allow health officials to monitor the spread of resistance, and help doctors and public health officers decide where the treatment is most likely to be effective.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health, Wellcome Trust, Bill & Melinda Gates Foundation, Medical Research Council, and UK Department for International Development

Contact: Samantha Wynne
press.office@sanger.ac.uk
122-349-2368
Wellcome Trust Sanger Institute

Public Release: 3-Nov-2016
More than 3 million children under 5 years old will die from infectious diseases next year
A new report outlines the alarming burden of pediatric infectious diseases across the world.
Global Hygiene Council

Contact: Catherine Major
catherine@spinkhealth.com
01-444-811-099
Global Hygiene Council

Public Release: 2-Nov-2016
Lancet Oncology
Safety concerns linger for generic oncology drugs in developing countries
Although generic oncology drugs can reduce patient costs and improve treatment access, the safety of these drugs in developing countries is uncertain, according to an international research team led by Dr. Charles Bennett, Josie M. Fletcher professor and chairman of the S.C. SmartState Center in Medication Safety and Efficacy at the College of Pharmacy at the University of South Carolina.
NIH/National Cancer Institute, SmartState/State of South Carolina

Contact: Laura Kammerer
laurakam@mailbox.sc.edu
803-777-4731
University of South Carolina

Public Release: 2-Nov-2016
World Journal of Surgery
WHO Trauma Care Checklist improves care for injured patients
Injury is responsible for more than 10 percent of the global burden of disease, killing more people each year than HIV, malaria and tuberculosis combined. More than 90 percent of these deaths occur in low- and middle-income countries. Injury is also the leading cause of death in adolescents globally.

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer

Public Release: 2-Nov-2016
BMC Medicine
Prevalence of drug-resistant tuberculosis in West Africa higher than previously thought
Multidrug-resistant tuberculosis could become a serious public health threat in West Africa unless effective surveillance and control measures are implemented, according to a study published in the open access journal BMC Medicine. Researchers from the West-African Network of Excellence for TB, AIDS and Malaria found the prevalence of multidrug-resistant tuberculosis to be unexpectedly high in eight West-African countries.
European Developing Countries Clinical Trial Partnership

Contact: Anne Korn
anne.korn@biomedcentral.com
44-020-319-22744
BioMed Central

Public Release: 1-Nov-2016
World Cancer Congress
Merck KGaA, Darmstadt, Germany, and American Cancer Society address cancer in women
Merck KGaA, Darmstadt, Germany, a leading science and technology company, and the American Cancer Society today released a report that shows all four of the top causes of cancer deaths in women worldwide are mostly preventable or can often be detected early, when treatment is more successful. The report, titled 'The Global Burden of Cancer in Women,' is the first tangible output from an innovative partnership between Merck KGaA, Darmstadt, Germany, and the ACS.
Merck KGaA, American Cancer Society

Contact: Gangolf Schrimpf
49-615-172-9591
Merck KGaA, Darmstadt, Germany

Public Release: 1-Nov-2016
PLOS Medicine
Ranking global risk factors for childhood stunting
The leading risk factor for childhood stunting is being born at term but small for gestational age, according to a 137-country analysis published in PLOS Medicine. The study, conducted by Goodarz Danaei of the Harvard T.H. Chan School of Public Health, Boston, USA, and colleagues, indicated that unimproved sanitation, poor nutrition, and infection were other important contributors to the burden of stunting.

Contact: Goodarz Danaei
gdanaei@hsph.harvard.edu
PLOS

Public Release: 31-Oct-2016
Gynecologic Oncology
Less than half of cervical cancer patients receive standard-of-care treatment
University of Colorado Cancer Center study shows that only 44 percent of patients in a large, national sample received all three components of standard-of-care treatment for cervical cancer, most often lacking brachytherapy.

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Anschutz Medical Campus

Public Release: 31-Oct-2016
American Journal of Clinical and Experimental Obstetrics and Gynecology
Chinese medical education rising unevenly from Cultural Revolution rubble
A new research review chronicling the history and current state of medical education in China finds that the country's quest to build up a medical education system to serve is massive population has produced a rapid, if uneven, result.

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 31-Oct-2016
Nature Physics
Mystery of tropical human parasite swimming solved by Stanford researchers
Bioengineers combined live observation, mathematical insights and robots to reveal the movement of parasitic larvae that cause schistosomiasis, a neglected tropical disease affecting millions of people worldwide.

Contact: Taylor Kubota
tkubota@stanford.edu
650-724-7707
Stanford University

Public Release: 28-Oct-2016
Scientific Reports
Ancient strain of cholera likely present in Haiti since colonial era
A non-virulent variant of the deadly Vibrio cholerae O1 strain has likely been present in Haitian aquatic environments for several hundred years, with the potential to become virulent through gene transfer with the toxigenic strain introduced by UN peacekeepers, according to research published today by scientists at the University of Florida's Emerging Pathogens Institute.

Contact: Glenn Morris
JGMorris@epi.ufl.edu
352-273-7526
University of Florida

Public Release: 28-Oct-2016
Plastic and Reconstructive Surgery
In low- to middle-income countries, barriers to cleft lip and palate surgery persist
Charitable organizations perform more than 80 percent of cleft lip and cleft palate surgeries in Vietnam -- reflecting the complex and persistent barriers to surgical care in low- to middle-income countries, according to a study in the November issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 28-Oct-2016
Neurology
Procedure feared to 'suck brain from skull' safe for malaria patients
A Michigan State University researcher is challenging a widely held African belief that a spinal tap, a procedure safely used to treat other diseases, could suck the brain from the base of the skull and cause death in malaria patients.

Contact: Sarina Gleason
sarina.gleason@cabs.msu.edu
517-355-9742
Michigan State University

Public Release: 27-Oct-2016
Scientific Reports
Enzyme is crucial for combatting antibiotic-resistant E. coli infections
Enzyme is crucial for combating antibiotic-resistant E. coli infections Research by bioscientists at the University of Kent and the University of Queensland is expected to pave the way for new approaches to kill bacteria that no longer respond to conventional antibiotics.

Contact: S.Fleming
S.Fleming@kent.ac.uk
44-012-278-23581
University of Kent

Public Release: 26-Oct-2016
ACS Nano
How nanoscience will improve our health and lives in the coming years
Nanoscience research involves molecules 100 times smaller than cancer cells with the potential to profoundly improve the quality of our health and our lives. Now nine prominent nanoscientists look ahead to what we can expect in the coming decade, and conclude that nanoscience is poised to make important contributions in many areas, including health care, electronics, energy, food and water.

Contact: Stuart Wolpert
swolpert@support.ucla.edu
310-206-0511
University of California - Los Angeles

Showing releases 326-350 out of 1337.

<< < 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 > >>